Skip to main content

Tweets

Beyond the Needle: Redefining the Assessment of Lupus Nephritis Lupus nephritis is one of the most silent and severe manifestations of systemic lupus erythematosus (SLE). https://t.co/fvGG0BZbOL #ACR24 https://t.co/wPXQz9Vese
Dr. John Cush @RheumNow ( View Tweet )
4 days 4 hours ago
Cancer Survival in RA Dr. Eric Dein interviews Joshua Hsieh about abstract 0474, Association Between Rheumatoid Arthritis and Survival After Cancer: A Systematic Literature Review and Meta-analysis, presented at #ACR24. https://t.co/2957Nq6Ajy https://t.co/3swVyigA3g
Dr. John Cush @RheumNow ( View Tweet )
4 days 5 hours ago
COVID Associated Immune Disease Dr. Len Calabrese reports on a session he participated in discussing if Covid-19 is associated or causal for autoimmune disease. Reporting from #ACR24 https://t.co/vFdlf9XVzf https://t.co/JhpglNVIt7
Dr. John Cush @RheumNow ( View Tweet )
4 days 6 hours ago
Finding the Right Combination Therapy in RA Dr. Jonathan Kay interviews Dr. Ernest Choy about abstract 0521, Transcriptome Analysis of Drug Response in a Large Cohort of Immune-Mediated Inflammatory Disease Patients Supports Advanced Combination Therapy in RA, presented at… https://t.co/yPmDIZ6aKI https://t.co/cairKrbDDu
Dr. John Cush @RheumNow ( View Tweet )
4 days 7 hours ago
RheumNow Day 4 Recap: ACR Convergence 2024 Highlights https://t.co/WvQB7y0bkm

Dr. John Cush @RheumNow ( View Tweet )

4 days 7 hours ago
RheumNow’s expanded coverage of the #ACR24 annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty

Dr. John Cush @RheumNow ( View Tweet )

4 days 7 hours ago
RheumNow’s expanded coverage of the #ACR24 Annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty

Dr. John Cush @RheumNow ( View Tweet )

4 days 7 hours ago
Time the💉 Response to pneumococcal vaccine better when given before starting MTX. Stay updated on ACR and EULAR vaccination recommendations! #ACR24 @RheumNow ABST#2676

Jiha Lee @JihaRheum ( View Tweet )

4 days 8 hours ago
How long before starting MTX should pts receive PCV13 vaccine? ➡️In RA, PCV13 vaccine given 1 month before starting MTX led to significantly higher immunological response at 1 month compared to pts vaccinated on MTX ⏩Vaccinate pts before starting MTX Ab2676 #ACR24 @RheumNow

Mrinalini Dey @DrMiniDey ( View Tweet )

4 days 8 hours ago
Abstract 2681: #SDOH factors & SLE risk: - Low income (AOR=2.779). - By race/ethnicity NHB (AOR=2.429), Hispanic (AOR=1.616). Behavioral: Psych distress (AOR=2.127), no exercise (AOR=1.677). Access: Medicaid (AOR=2.540), transport barriers (AOR=20.394). @RheumNow #ACR24

Akhil Sood MD @AkhilSoodMD ( View Tweet )

4 days 8 hours ago
For daily recaps, content and updates from #ACR24 head to https://t.co/eL0bMhnFiu @RheumNow with input from colleagues in the faculty @synovialjoints @bella_mehta @ericdeinmd @AkhilSoodMD. @DrMiniDey @CaoilfhionnMD @ebrhuem @rheumarampa @Dr_Brian_MD @AdelaCastro222 @JihaRheum… https://t.co/a3FQjGokhn https://t.co/1g3Fi01HWG
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
4 days 8 hours ago
#Ianalumab 300 mg sc q monthly B cell depleted and changes BAFF signalling 👇⬇️IFN May be promising in #lupus #SLE +data in primary #Sjogrens ACR24 @RheumNow @ACRheum Abst#2425 Needs Phase3 ➡️I suspect safer than CAR T and Bispecific T cell engagers but ? ⬇️efficacy

Janet Pope @Janetbirdope ( View Tweet )

4 days 8 hours ago